These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22718307)

  • 1. The influence of non-clinical patient factors on medical oncologists' decisions to recommend breast cancer adjuvant chemotherapy.
    Pini TM; Hawley ST; Li Y; Katz SJ; Griggs JJ
    Breast Cancer Res Treat; 2012 Jul; 134(2):867-74. PubMed ID: 22718307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer.
    Kurian AW; Bondarenko I; Jagsi R; Friese CR; McLeod MC; Hawley ST; Hamilton AS; Ward KC; Hofer TP; Katz SJ
    J Natl Cancer Inst; 2018 May; 110(5):493-500. PubMed ID: 29237009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives and attitudes on the use of adjuvant chemotherapy and trastuzumab in older adults with HER-2+ breast cancer: a survey of oncologists.
    Hurria A; Wong FL; Pal S; Chung CT; Bhatia S; Mortimer J; Somlo G; Hurvitz S; Villaluna D; Naeim A
    Oncologist; 2009 Sep; 14(9):883-90. PubMed ID: 19726455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologists' influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer?
    Katz SJ; Hawley ST; Bondarenko I; Jagsi R; Ward KC; Hofer TP; Kurian AW
    Breast Cancer Res Treat; 2017 Oct; 165(3):751-756. PubMed ID: 28689364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second Opinions From Medical Oncologists for Early-Stage Breast Cancer: Prevalence, Correlates, and Consequences.
    Kurian AW; Friese CR; Bondarenko I; Jagsi R; Li Y; Hamilton AS; Ward KC; Katz SJ
    JAMA Oncol; 2017 Mar; 3(3):391-397. PubMed ID: 28033448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women.
    Hershman DL; Buono D; McBride RB; Tsai WY; Neugut AI
    Cancer; 2009 Sep; 115(17):3848-57. PubMed ID: 19517470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancer.
    Jagsi R; Abrahamse P; Morrow M; Hawley ST; Griggs JJ; Graff JJ; Hamilton AS; Katz SJ
    J Clin Oncol; 2010 May; 28(14):2396-403. PubMed ID: 20351324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologists' recommendations for adjuvant therapy in hormone receptor-positive breast cancer patients of varying age and health status.
    Naeim A; Wong FL; Pal SK; Hurria A
    Clin Breast Cancer; 2010 Apr; 10(2):136-43. PubMed ID: 20353934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordination of breast cancer care between radiation oncologists and surgeons: a survey study.
    Jagsi R; Abrahamse P; Morrow M; Hamilton AS; Graff JJ; Katz SJ
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2072-8. PubMed ID: 21477932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Radiation Oncologists on the Early Adoption of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer.
    Boero IJ; Gillespie EF; Hou J; Paravati AJ; Kim E; Einck JP; Yashar C; Mell LK; Murphy JD
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):571-580. PubMed ID: 28126306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community Oncologists' Decision-Making for Treatment of Older Patients With Cancer.
    Mohile SG; Magnuson A; Pandya C; Velarde C; Duberstein P; Hurria A; Loh KP; Wells M; Plumb S; Gilmore N; Flannery M; Wittink M; Epstein R; Heckler CE; Janelsins M; Mustian K; Hopkins JO; Liu J; Peri S; Dale W
    J Natl Compr Canc Netw; 2018 Mar; 16(3):301-309. PubMed ID: 29523669
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant chemotherapy in node negative breast cancer: patterns of use and oncologists' preferences.
    Stiggelbout AM; de Haes JC; van de Velde CJ
    Ann Oncol; 2000 May; 11(5):631-3. PubMed ID: 10907961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists.
    Hurria A; Naeim A; Elkin E; Limaye S; Grover A; Hudis C; Pearce C; Robson M
    Crit Rev Oncol Hematol; 2007 Mar; 61(3):255-60. PubMed ID: 17098441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologists' weighing of the benefits and side effects of adjuvant systemic therapy: Has it changed over time?
    Engelhardt EG; de Haes HC; van de Velde CJ; Smets EM; Pieterse AH; Stiggelbout AM
    Acta Oncol; 2015 Jun; 54(6):956-9. PubMed ID: 25591819
    [No Abstract]   [Full Text] [Related]  

  • 15. Influences on oncologists' adoption of new agents in adjuvant chemotherapy of breast cancer.
    Buban GM; Link BK; Doucette WR
    J Clin Oncol; 2001 Feb; 19(4):954-9. PubMed ID: 11181657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient demographic and tumor characteristics influencing oncologist follow-up frequency in older breast cancer survivors.
    Neuman HB; Weiss JM; Schrag D; Ronk K; Havlena J; LoConte NK; Smith MA; Greenberg CC
    Ann Surg Oncol; 2013 Dec; 20(13):4128-36. PubMed ID: 23943027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy for breast cancer: discordance between physicians' perception of benefit and the results of clinical trials.
    Rajagopal S; Goodman PJ; Tannock IF
    J Clin Oncol; 1994 Jun; 12(6):1296-304. PubMed ID: 8201392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptance of adjuvant chemotherapy recommendations in early-stage hormone-positive breast cancer.
    Marcinkowski EF; Ottesen R; Niland J; Vito C
    J Surg Res; 2017 Jun; 214():79-85. PubMed ID: 28624063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary care provider-reported involvement in breast cancer treatment decisions.
    Wallner LP; Li Y; McLeod MC; Gargaro J; Kurian AW; Jagsi R; Radhakrishnan A; Hamilton AS; Ward KC; Hawley ST; Katz SJ
    Cancer; 2019 Jun; 125(11):1815-1822. PubMed ID: 30707773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Changing Role of Gene-Expression Profiling in the Era of De-escalating Adjuvant Chemotherapy in Early-Stage Breast Cancer.
    van Steenhoven JEC; Kuijer A; Schreuder K; Elias SG; van Diest PJ; van der Wall E; Siesling S; van Dalen T
    Ann Surg Oncol; 2019 Oct; 26(11):3495-3501. PubMed ID: 31209664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.